Interleukin-1 mediates Alzheimer and Lewy body pathologies

Journal of Neuroinflammation

Volumn 3, Issue , 2006, Pages

  Griffin, W Sue T ^a,b,c   Liu, Ling ^a   Li, Yuekui ^a   Mrak, Robert E ^b   Barger, Steven W ^a,b,c  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID PRECURSOR PROTEIN; BOVINE SERUM ALBUMIN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; SYNAPTOPHYSIN; TAU PROTEIN;

AGED; ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CELL ACTIVATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RELEASE; DIFFUSE LEWY BODY DISEASE; ENZYME ACTIVATION; FEMALE; FETUS; HUMAN; HUMAN TISSUE; LEWY BODY; MALE; MICROGLIA; MIXED CELL CULTURE; NERVE CELL CULTURE; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NEWBORN; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE SECTION;

EID: 33645809729     PISSN: 17422094     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-3-5     Document Type: Article

References (44)

1. Galvin JE, Lee VM, Trojanowskii JQ: Synucleinopathies: clinical and pathological implications. Arch Neural 2001, 58:186-190.
2. Hurtig HI, Trojanowski JQ, Galvin J, Ewbank D, Schmidt ML, Lee VM, Clark CM, Glosser G, Stern MB, Gollomp SM, Arnold SE: α-Synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease. Neurology 2000, 54:1916-1921.
3. Lippa CF, Schmidt ML, Lee VM, Trojanowski JQ: α-Synuclein in familial Alzheimer disease: epitope mapping parallels dementia with Lewy bodies and Parkinson disease. Arch Neurol 2001, 58:1817-1820.
4. Mirza B, Hadberg H, Thomsen P, Moos T: The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson's disease. Neuroscience 2000, 95:425-432.
5. Mrak RE, Griffin WS: Glia and their cytokines in progression of neurodegeneration. Neurobiol Aging 2005, 26:349-354.
6. Griffin WS, Stanley LC, Ling C, White L, MacLeod V, Perrot Lj, White CLd, Araoz C: Brain interleukin I and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci USA 1989, 86:7611-7615.
7. Stanley LC, Mrak RE, Woody RC, Perrot LJ, Zhang S, Marshak DR, Nelson SJ, Griffin WS: Glial cytokines as neuropathogenic factors in HIV infection: pathogenic similarities to Alzheimer's disease. J Neuropathol Exp Neural 1994, 53:231-238.
8. Esiri MM, Biddolph SC, Morris CS: Prevalence of Alzheimer plaques in AIDS. J Neurol Neurosurg Psychiatry 1998, 65:29-33.
9. Sheng JG, Boop FA, Mrak RE, Griffin WS: Increased neuronal β-amyloid precursor protein expression in human temporal lobe epilepsy: association with interleukin-I α immunoreactivity. J Neurochem 1994, 63:1872-1879.
10. Mackenzie IR, Miller LA: Senile plaques in temporal lobe epilepsy. Acta Neuropothol (Berl) 1994, 87:504-510.
11. Griffin WS, ShengJG, Gentleman SM, Graham DI, Mrak RE, Roberts GW: Microgliall interleukin-I α expression in human head injury: correlations with neuronal and neuritic β-amyloid precursor protein expression. Neurosci Lett 1994, 176:133-136.
12. Li Y, Liu L, Kang J, Sheng JG, Barger SW, Mrak RE, Griffin WS: Neuronal-glial interactions mediated by interleukin-I enhance neuronall acetylcholinesterase activity and mRNA expression. J Neurosci 2000, 20:149-155.
13. Toiber D, Soreq H: Cellular stress reactions as putative cholinergic links in Alzheimer's disease. Neurochem Res 2005, 30:909-919.
14. Wenk GL, McGann K, Hauss-Wegrzyniak B, Rosi S: The toxicity of tumor necrosis factor-α upon cholinergic neurons within the nucleus basalis and the role of norepinephrine in the regulation of inflammation: implications for Alzheimer's disease. Neuroscience 2003, 121:719-729.
15. Barger SW, Basile AS: Activation of microglia by secreted amyloid precursor protein evokes release of glutamate by cystine exchange and attenuates synaptic function. J Neurochem 2001, 76:846-854.
16. Rosi S, Ramirez-Amaya V, Hauss-Wegrzyniak B, Wenk GL: Chronic brain inflammation leads to a decline in hippocampal NMDA-RI receptors. J Neuroinflammation 2004,1:12.
17. Wu SZ, Bodles AM, Porter MM, Griffin WS, Basile AS, Barger SW: Induction of serine racemase expression and D-serine release from microglia by amyloid β-peptide. J Neuroinflammation 2004, 1:2.
18. Li Y, Liu L, Barger SW, Griffin WS: Interieukin-I mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway. J Neurosci 2003, 23:1605-1611.
19. Li Y, Wang J, Sheng JG, Liu L, Barger SW, Jones RA, Van Eldik LJ, Mrak RE, Griffin WS: S100 β increases levels of β-amyloid precursor protein and its encoding mRNA in rat neuronall cultures. J Neurochem 1998, 71:1421-1428.
20. Barger SW, Harmon AD: Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature 1997, 388:878-881.
21. Sheng JG, Jones RA, Zhou XQ, McGinness JM, Van Eldik LJ, Mrak RE, Griffin WS: Interleukin-I promotion of MAPK-p38 overexpression in experimental animals and in Alzheimer's disease: potential significance for tau protein phosphorylation. Neurochem Int 2001, 39:341-348.
22. Griffin WS, Mrak RE: Interleukin-I in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's disease. J Leukoc Biol 2002, 72:233-238.
23. Greenberg SM, Koo EH, Selkoe DJ, Qiu WQ, Kosik KS: Secreted β-amyloid precursor protein stimulates mitogen-activated protein kinase and enhances tau phosphorylation. Proc Natl Acad Sci USA 1994, 91:7104-7108.
24. Bodies AM, Barger SW: Secreted β-amyloid precursor protein activates microglia via JNK and p38-MAPK. Neurobiol Aging 2005, 26:9-16.
25. Barger SW, Chavis JA, Drew PD: Dehydroepiandrosterone inhibits microglial nitric oxide production in a stimuius-specific manner. J Neurosci Res 2000, 62:503-509.
26. Mrak RE, Griffin WS: Interleukin-I and the immunogenetics of Alzheimer disease. J Neuropathol Exp Neural 2000, 59:471-476.
27. Goldgaber D, Harris HW, Hla T, Maciag T, Donnelly RJ, Jacobsen JS, Vitek MP, Gajdusek DC: Interieukin I regulates synthesis of amyloid β-protein precursor mRNA in human endothelial cells. Proc Natl Acad Sci USA 1989, 86:7606-7610.
28. Rogers JT, Randall JD, Cahill CM, Eder PS, Huang X, Gunshin H, Leiter L, McPhee J, Sarang SS, Utsuki T, Greig NH, Lahiri DK, Tanzi RE, Bush AI, Giordano T, Gullans SR: An iron-responsive element type II in the 5′-untranslated region of the Alzheimer's amyloid precursor protein transcript. J Natl Chem 2002, 277:45518-45528.
29. Blasko I, Veerhuis R, Stampfer-Kountchev M, Saurwein-Teissl M, Eikelenboom P, Grubeck-Loebenstein B: Costimulatory effects of interferon-γ and interleukin-Iβ or tumor necrosis factor α on the synthesis of Aβ 1-40 and Aβ 1-42 by human astrocytes. Neurobiol Dis 2000, 7:682-689.
30. Buxbaum JD, Oishi M, Chen HI, Pinkas-Kramarski R, Jaffe EA, Gandy SE, Greengard P. Cholinergic agonists and interieukin I regulate processing and secretion of the Alzheimer β/A4 amyloid protein precursor. Proc Natl Acad Sci USA 1992, 89:10075-10078.
31. Liao YF, Wang BJ, Cheng HT, Kuo LH, Wolfe MS: Tumor necrosis factor-α, interleukin-Iβ, and interferon-γ stimulate y-secretase-mediated cleavage of amyloid precursor protein through a JNK-dependent MAPK pathway. J Biol Chem 2004, 279:49523-49532.
32. Ma G, Chen S, Wang X, Ba M, Yang H, Lu G: Short-term interleukin-I(β) increases the release of secreted APP(α) via MEKI/2-dependent and JNK-dependent α-secretase cleavage in neuroglioma U251 cells. J Neurosci Res 2005, 80:683-692.
33. Vereker E, O'Donnell E, Lynch MA: The inhibitory effect of interleukin-Iβ on long-term potentiation is coupled with increased activity of stress-activated protein kinases. J Neurosci 2000, 20:6811-6819.
34. Chandra S, Gallardo G, Fernandez-Chacon R, Schluter OM, Sudhof TC: α-Synuclein cooperates with CSPα in preventing neurodegeneration. Cell 2005, 123:383-396.
35. Tanli K, Mori F, Imaizumi T, Yoshida H, Matsumiya T, Tamo W, Yoshimoto M, Odagiri H, Sasaki M, Takahashi H, Satoh K, Wakabayashi K: Upregulation of α-synuclein by lipopolysaccharide and interleukin-I in human macrophages. Pathol Int 2002, 52:572-577.
36. Tanji K, Imaizumi T, Yoshida H, Mori F, Yoshimoto M, Satoh K, Wakabayashi K: Expression of α-synuclein in a human glioma cell line and its up-regulation by interleukin-Iβ. Neuroreport 2001, 12:1909-1912.
37. Satoh JI, Kuroda Y: α-Synuclein expression is up-regulated in NTera2 cells during neuronal differentiation but unaffected by exposure to cytokines and neurotrophic factors. Parkinsonism Relat Disord 2001, 8:7-17.
38. Mori F, Tanji K, Yoshimoto M, Takahashi H, Wakabayashi K. Demonstration of α-synuclein immunoreactivity in neuronal and glial cytoplasm in normal human brain tissue using proteinase K and formic acid pretreatment. Exp Neural 2002, 176:98-104.
39. Wakabayashi K, Hayashi S, Yoshimoto M, Kudo H, Takahashi H: NACP/ α-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson's disease brains. Acta Neuropathol (Berl) 2000, 99:14-20.
40. Baba M, Nakajo S, Tu PH, Tomita T, Nakaya K, Lee VM, Trojanowski JQ, Iwatsubo T. Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol 1998, 152:879-884.
41. Campbell BC, Li QX, Culvenor JG, Jakala P, Cappai R, Beyreuther K, Masters CL, McLean CA: Accumulation of insoluble α-synuclein in dementia with Lewy bodies. Neurubiol Dis 2000, 7:192-200.
42. Masliah E, Rockenstein E, Veinbergs I, Sagara Y, Mallory M, Hashimoto M, Mucke L: β-amyloid peptides enhance α-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease. Proc Natl Acad Sci USA 2001, 98:12245-12250.
43. Pletnikova O, West N, Lee MK, Rudow GL, Skolasky RL, Dawson TM, Marsh L, Troncoso JC: Aβ deposition is associated with enhanced cortical α-synuclein lesions in Lewy body diseases. Neurobiol Aging 2005, 26:1183-1192.
44. Rothwell N: Interleukin-I and neuronal injury: mechanisms, modification, and therapeutic potential. Brain Behav Immun 2003, 17:152-157.